# Randomized Open Investigation Determining Steroid Dose

> **NCT04834375** · PHASE3 · COMPLETED · sponsor: **Northwell Health** · enrollment: 142 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Weight-based dexamethasone dose

## Key facts

- **NCT ID:** NCT04834375
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-19
- **Primary completion:** 2022-01-25
- **Final completion:** 2022-03-29
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834375, "Randomized Open Investigation Determining Steroid Dose". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04834375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
